Patents by Inventor Seth Ritter

Seth Ritter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965190
    Abstract: Provided herein are a vector, a genetically modified bacterium including the vector, methods of making the bacterium, methods of using the bacterium, and kits including the bacterium. The vector includes a coding region encoding at least one antimicrobial peptide, and the antimicrobial peptide includes at least one lysin.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: April 23, 2024
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Yiannis John Kaznessis, Seth Ritter, Benjamin Hackel
  • Publication number: 20230340446
    Abstract: Aspects of the disclosure relate to biosynthesis of cannabinoids and cannabinoid precursors in recombinant cells and in vitro. In particular, the disclosure relates to variants of olivetolic acid cyclase.
    Type: Application
    Filed: June 17, 2021
    Publication date: October 26, 2023
    Applicant: Ginkgo Bioworks, Inc.
    Inventors: Kim Cecelia Anderson, Brian Carvalho, Nicholas Flores, Seth Ritter, Gabriel Rodriguez, Michelle Spencer, Emily E. Wrenbeck
  • Publication number: 20230063093
    Abstract: The present disclosure provides host cells, e.g., bacterial cells, that comprise a methionine decarboxylase enzyme for the treatment of diseases and disorders associated with methionine metabolism in a subject. The disclosure further provides pharmaceutical compositions and methods of treating disorders associated with methionine metabolism, such as homocystinuria.
    Type: Application
    Filed: August 11, 2022
    Publication date: March 2, 2023
    Inventors: Dylan Alexander Carlin, Vincent M. Isabella, Jonathan McMurry, Theodore Carlton Moore, III, Mylene Perreault, Seth Ritter, Nathan Schmidt, Mark Simon
  • Publication number: 20210269786
    Abstract: Provided herein are a vector, a genetically modified bacterium including the vector, methods of making the bacterium, methods of using the bacterium, and kits including the bacterium. The vector includes a coding region encoding at least one antimicrobial peptide, and the antimicrobial peptide includes at least one lysin.
    Type: Application
    Filed: September 7, 2018
    Publication date: September 2, 2021
    Inventors: Yiannis John Kaznessis, Seth Ritter, Benjamin Hackel
  • Publication number: 20200299665
    Abstract: Provided herein are a vector, a genetically modified bacterium including the vector, methods of making the bacterium, methods of using the bacterium, and kits including the bacterium. The vector includes a coding region encoding at least one antimicrobial peptide, and the antimicrobial peptide includes at least one lysin.
    Type: Application
    Filed: September 7, 2018
    Publication date: September 24, 2020
    Inventors: Yiannis John Kaznessis, Seth Ritter, Benjamin Hackel